Netherlands Artificial Organs & Bionic Implants Market Size (2024 - 2029)

The Netherlands Artificial Organs & Bionic Implants Market is anticipated to experience significant growth, driven by factors such as the rising prevalence of disabilities and organ failures, along with increasing healthcare expenditure. Technological advancements and heightened awareness of bionics and artificial organs are further contributing to the expansion of the market. The prevalence of cardiovascular diseases, particularly ischemic heart disease and hypertension, has led to a heightened demand for cardiac bionics, thereby influencing the market size positively.

Market Size of Netherlands Artificial Organs & Bionic Implants Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 11.58 %

Major Players

Netherlands Artificial Organs & Bionic Implants Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Netherlands Artificial Organs & Bionic Implants Market Analysis

The Netherlands Artificial Organs & Bionic Implants Market is expected to grow with a CAGR of 11.58% during the forecast period. The growth of the market can be attributed to the increasing prevalence of disabilities and organ failures and rising healthcare expenditure. Furthermore, the technological advancements and growing awareness of bionics and artificial organs is further boosting the market growth.

In the Netherlands, ischemic heart disease is found to be the leading cause of death for a long time. Based on self-reported data from the European Health Interview Survey (EHIS), one in six people in the Netherlands lives with hypertension which is a major risk factor for cardiovascular disease. Cardiovascular diseases are thus found to have a major share in the deaths of the country that has increased cardiovascular disease patients. With the increase in cardiovascular disease patients, there is a high demand for cardiac bionics that helps in boosting the market growth.

Netherlands Artificial Organs & Bionic Implants Industry Segmentation

As per the scope of the report, artificial organs and bionic implants are the man-made devices that can be implanted or integrated into humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to return to his normal life.

By Product
Artificial Organs
Artificial Heart
Artificial Kidney
Others
Bionics
Vision Bionics
Orthopedic Bionic
Cardiac Bionics
Others
Need A Different Region Or Segment?
Customize Now

Netherlands Artificial Organs & Bionic Implants Market Size Summary

The Netherlands Artificial Organs & Bionic Implants Market is poised for significant expansion, driven by the rising incidence of disabilities and organ failures, alongside increasing healthcare expenditures. Technological advancements and heightened awareness of bionics and artificial organs are further propelling market growth. The prevalence of ischemic heart disease and hypertension, major risk factors for cardiovascular diseases, has led to a substantial demand for cardiac bionics. This demand is fueled by the growing number of cardiovascular disease patients, which in turn is boosting the market for artificial organs and bionic implants.

Additionally, the market is experiencing growth due to the increasing number of road accidents and injuries necessitating amputations, as well as a rising geriatric population requiring knee transplants and other joint replacements. The substantial number of replacement surgeries, coupled with the expanding patient pool and developing healthcare facilities, is contributing to the market's expansion. The competitive landscape is characterized by several major players employing strategies such as agreements, collaborations, business expansions, and product developments to strengthen their market position.

Explore More

Netherlands Artificial Organs & Bionic Implants Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Disabilities and Organ Failures and Rising Healthcare Expenditure

      2. 1.2.2 Technological Advancements and Growing Awareness of Bionics and Artificial Organs

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Procedures and Fear of Device Malfunction and its Consequences

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Artificial Organs

        1. 2.1.1.1 Artificial Heart

        2. 2.1.1.2 Artificial Kidney

        3. 2.1.1.3 Others

      2. 2.1.2 Bionics

        1. 2.1.2.1 Vision Bionics

        2. 2.1.2.2 Orthopedic Bionic

        3. 2.1.2.3 Cardiac Bionics

        4. 2.1.2.4 Others

Netherlands Artificial Organs & Bionic Implants Market Size FAQs

The Netherlands Artificial Organs & Bionic Implants Market is projected to register a CAGR of 11.58% during the forecast period (2024-2029)

Boston Scientific Corporation, Medtronic plc, Reboocon Bionics B.V., Otto Bock Holding GmbH & Co. KG and Ossur are the major companies operating in the Netherlands Artificial Organs & Bionic Implants Market.

Netherlands Artificial Organs & Bionic Implants Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)